Results 111 to 120 of about 6,571 (189)

Safety and Tolerability of Vildagliptin 100 mg Sustained-Release Formulation in Type 2 Diabetes Mellitus: Results From a Prospective, Multicenter, Single-Arm, Post-marketing Surveillance Study. [PDF]

Cureus
Soni P, Sonawane A, Gaidhani S, Baxi N, Malhotra D, Acharya S.   +5 more
europepmc   +1 more source

Docosahexaenoic acid is comparable to vildagliptin in improving hyperglycemia and pancreatic insulin signaling of diabetic rats via SIRT1/Akt/PI3K pathway. [PDF]

Sci Rep
Abo-Saif MA, Werida RH, Mohamed SA, Khedr NF.   +3 more
europepmc   +1 more source

Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS. [PDF]

In Vivo
Ohyama K, Takahashi T, Akiyama S, Hori Y.   +3 more
europepmc   +1 more source

Longitudinal Changes in Corneal Epithelial and Central Corneal Thickness in Type 2 Diabetes Assessed by AS-OCT: A Real-World Study. [PDF]

Clin Ophthalmol
Boyacı İ, Demirci G.
europepmc   +1 more source

Surfing the vildagliptin tsunami

Indian Journal of Endocrinology and Metabolism, 2020
openaire   +3 more sources

Monocyte dipeptidyl peptidase 4 activity is associated with urinary albumin excretion in type 2 diabetes. [PDF]

J Diabetes Investig
Okuma H, Tsutsumi T, Tsuchiya K.
europepmc   +1 more source

Ameliorative effects of Wiryeongtang (herbal medicine) on cardiorenal complications via modulation of inflammatory and fibrotic responses in diabetic mice. [PDF]

Integr Med Res
Yoon JJ, Kim HY, Tai AL, Yang YJ, Park SJ, Lee HS.   +5 more
europepmc   +1 more source

Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin (850/50mg) in healthy Tunisian subjects under fed conditions. [PDF]

Sci Rep
Ferchichi K, Gaies E, Ben Hammamia S, El Jebari H, Daldoul M, Ghorbel S, Srairi S, Guermazi S, Gorgi Y, Boutiba I, Bouzid K, Abbessi A, Daghfous R, Ben Sassi M, Trabelsi S.   +14 more
europepmc   +1 more source

Assessing the therapeutic effects of DPP4 Inhibitors on TGF-β2-induced Lens Opacity. [PDF]

Exp Eye Res
Talebian N, Liu PK, Lee J, Lin YL, Stavropoulos D, Chen CY, Chang KC.   +6 more
europepmc   +1 more source

Evaluation of the therapeutic effect of new hypoglycemic drugs on patients with heart failure with reduced ejection fraction and type 2 diabetes: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Chen XR, Mao XP, Luo D, Yu CQ, Bai JN.
europepmc   +1 more source